Search

everythinglearnresearchcommunity

for

Search:↓

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Vitamin C derivative helps hair grow longer by making cells produce a growth factor through a specific cellular pathway.

Stressed fibroblasts greatly increase melanin production in hair, skin, and eye cells, mainly due to a growth factor called bFGF.

Increasing the levels of a protein called FGF9 can promote hair growth, but humans may not respond the same way due to a lack of certain cells.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Antibody treatments show promise for hair loss but need more research.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

The anti-CXCL4 antibody helps mice grow hair faster and prevents hair loss.

Ostrich antibodies helped regrow hair in men with hair loss, but the application needs to be easier.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

Gray hair can potentially be reversed, leading to new treatments.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.